Top Markets
Coin of the day
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Rangering i aksjer #93
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Aksjekurs
$137.21
Markedsverdi
$170.34B
Endring (1 dag)
-2.76%
Endring (1 år)
28.14%
Land
US
Handel Gilead Sciences, Inc. (GILD)

Kategori

Aksjeprishistorikk for Gilead Sciences, Inc. (GILD)
Høyeste sluttskurs: $145.05 den 2026-03-01

Laveste sluttskurs: $0.68 den 1992-01-01
Aksjeprishistorikk for Gilead Sciences, Inc. fra 1992 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -2.54%
2025 32.61%
2024 15.91%
2023 -8.13%
2022 21.80%
2021 20.36%
2020 -10.67%
2019 1.05%
2018 -11.26%
2017 0.81%
2016 -28.48%
2015 2.18%
2014 36.94%
2013 97.78%
2012 89.44%
2011 6.01%
2010 -17.54%
2009 -5.59%
2008 2.32%
2007 41.69%
2006 23.58%
2005 49.12%
2004 22.34%
2003 58.83%
2002 9.38%
2001 62.12%
2000 85.71%
1999 27.06%
1998 -1.72%
1997 35.42%
1996 -4.72%
1995 201.95%
1994 -24.84%
1993 -22.36%
1992 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$906.59 8.24%
US
$183.60 145.03%
GB
$235.37 43.84%
US
$205.07 -2.35%
US
$146.03 30.23%
CH